Founded by Bernie Schaeffer, we provide stock news, options insights, and premium trading services to options traders

 

BACKED BY 170+ YEARS OF MARKET EXPERTISE

Get Schaeffer’s market outlook every Monday, straight to your inbox.

 

 
 
 
 
 
 
 
 
X
Draftkings stock, DKNG stock, DKNG stock price
Shares of DraftKings Inc (NASDAQ:DKNG) are up 7.6% at $26.67, after the company reported strong May prediction markets growth, with annualized consumer trading volume rising 24% to $1.3 billion and to ... Shares of DraftKings Inc (NASDAQ:DKNG) are up 7.6% at $26.67, after the company reported strong May prediction markets growth, with annualized consumer trading volume rising 24% to $1.3 billion and total volume climbing 34% to $3.1 billion. The update highlights increasing adoption of its nationwide ... Keep Reading
Schaeffer’s Midday Market Check Daily Newsletter
Stocks are lower across the board, reversing this morning's gains as the chip rally fizzles. The Nasdaq Composite Index (IXIC) is down a whopping 504 points, while the S&P 500 Index (SPX) and Dow ... Stocks are lower across the board, reversing this morning's gains as the chip rally fizzles. The Nasdaq Composite Index (IXIC) is down a whopping 504 points, while the S&P 500 Index (SPX) and Dow Jones Industrial Average (DJI) sit firmly in the red as well. Meanwhile, West Texas Intermediate (W ... Keep Reading
Bearish outlook, bearish, sell off, bearish market, downtrend
Shares of Vail Resorts Inc (NYSE:MTN) are plunging 3.5% to trade at $132.45 out of the gate, sinking after the company shared a fiscal third-quarter earnings miss on revenue that matched expectations. ... Shares of Vail Resorts Inc (NYSE:MTN) are plunging 3.5% to trade at $132.45 out of the gate, sinking after the company shared a fiscal third-quarter earnings miss on revenue that matched expectations. The $8.81 earnings per share and $1.21 billion in revenue were followed up with a cut to the compan ... Keep Reading
Drugs sector news and analysis
Nuvalent Inc (NASDAQ:NUVL) is soaring in premarket trading, up 38.9% to trade at $122.88, after London-based GSK agreed to acquire the cancer drug developer in an all-cash deal valued at approximately ... Nuvalent Inc (NASDAQ:NUVL) is soaring in premarket trading, up 38.9% to trade at $122.88, after London-based GSK agreed to acquire the cancer drug developer in an all-cash deal valued at approximately $10.6 billion. Under the terms of the agreement, GSK will pay $124 per share, representing a roughl ... Keep Reading